Uses for recombinant human TSH in patients with thyroid cancer and nodular goiter

Clinical Endocrinology

Volumn 61, Issue 2, 2004, Pages 163-173

  Woodmansee, Whitney W ^a   Haugen, Bryan R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE 131; RECOMBINANT THYROTROPIN; THYROGLOBULIN;

CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CLINICAL TRIAL; CONGENITAL HYPOTHYROIDISM; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG APPROVAL; DRUG INDICATION; DRUG WITHDRAWAL; HISTORY OF MEDICINE; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; INTERMETHOD COMPARISON; NODULAR GOITER; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; WHOLE BODY SCINTISCANNING;

ADJUVANTS, PHARMACEUTIC; ANTINEOPLASTIC AGENTS; GOITER, NODULAR; HUMANS; IODINE RADIOISOTOPES; RECOMBINANT PROTEINS; THYROGLOBULIN; THYROID NEOPLASMS; THYROTROPIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 4143112298     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2004.02025.x     Document Type: Review

References (69)

1. Barbaro, D., Boni, G., Meucci, G., Simi, U., Lapi, P., Orsini, P., Pasquini, C., Piazza, F. & Caciagli, Mariani, G. (2003) Radio-iodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: Effectiveness for postsurgical remnant ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. Journal of Clinical Endocrinology and Metabolism, 89, 4110-4115.
2. Berg, G., Lindstedt, G., Suurkula, M. & Jansson, S. (2002) Radio-iodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone. Journal of Endocrinological Investigation, 25, 44-52.
3. Cailleux, A.F., Baudin, E., Travagli, J.P., Ricard, M. & Schlumberger, M. (2000) Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer? Journal of Clinical Endocrinology and Metabolism, 85, 175-178.
4. Chin, B.B., Patel, P., Cohade, C., Ewertz, M., Wahl, R. & Ladenson, P. (2004) Recombinant human thyrotropin stimulation of flouro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 89, 91-95.
5. Chiu, A.C., Delpassand, E.S. & Sherman, S.I. (1997) Prognosis and treatment of brain metastases in thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 82, 3637-3642.
6. Colleran, K.M. & Burge, M.R. (1999) Isolated thyrotropin deficiency secondary to primary empty sella in a patient with differentiated thyroid carcinoma: an indication for recombinant thyrotropin. Thyroid, 9, 1249-1252.
7. Colzani, R.M., Alex, S., Fang, S.L., Braverman, L.E. & Emerson, C.H. (1998) The effect of recombinant human thyrotropin (rhTSH) on thyroid function in mice and rats. Thyroid, 8, 797-801.
8. David. A., Blotta, A., Bondanelli, M., Rossi, R., Roti, E., Braverman, L.E., Busutti, L. & degli Uberti, E.C. (2001) Serum thyroglobulin concentrations and 131, I whole-body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid-stimulating hormone. Journal of Nuclear Medicine, 42, 1470-1475.
9. Demers, L.M. & Spencer, C.A., eds. (2002) Laboratory Medicine Practice Guidelines: Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. National Academy of Clinical Biochemistry (www.ncab.org), Washington, DC.
10. Dow, K.H., Ferrell, B.R. & Anella, C. (1997) Quality of Life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy. Thyroid, 7, 613-619.
11. Duick, D.S. & Baskin, H.J. (2003) Utility of recombinant human thyrotropin for augmentation of radio-iodine uptake and treatment of nontoxic and toxic multinodular goiters. Endocrine Practice, 9, 204-209.
12. Filetti, S., Damante, G. & Foti, D. (1987) Thyrotropin stimulates glucose transport in cultured rat thyroid cells. Endocrinology, 120, 2576-2581.
13. Fugazzola, L., Persani, L., Mannavola, D., Reschini, E., Vannucchi, G., Weber, G., Beck-Peccoz, P. (2003) Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during, L-thyroxine replacement. Clinical Endocrinology, 59, 230-236.
14. Giovanni, V., Arianna, L.G., Antonio, C., Francesco, F., Michele, K., Giovanni, S., Marco, S. & Giovanni, L. (2002) The use of recombinant human TSH in the follow-up of differentiated thyroid cancer: experience from a large patient cohort in a single centre. Clinical Endocrinology, 56, 247-252.
15. Guidon, P.T. Jr, Whitfield, G.K., Porti, D. & Kourides, I.A. (1988) The human thyrotropin beta-subunit gene differs in 5′ structure from murine TSH-beta genes. DNA, 7 (10), 691-699.
16. Haugen, B.R. (1999) Management of the patient with progressive radio-iodine non-responsive disease. Seminars in Surgical Oncology, 16, 34-41.
17. Haugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., Cooper, D.S., Graham, K.E., Braverman, L.E., Skarulis, M.C., Davies, T.F., DeGroot, L.J., Mazzaferri, E.L., Daniels, G.H., Ross, D.S., Luster, M., Samuels, M.H., Becker, D.V., Maxon, H.R., 3rd, Cavalieri, R.R., Spencer, C.A., McEllin, K., Weintraub, B.D. & Ridgway, E.C. (1999) A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Journal of Clinical Endocrinology and Metabolism, 84, 3877-3885.
18. Haugen, B.R., Ridgway, E.C., McLaughlin, B.A. & McDermott, M.T. (2002) Clinical comparison of whole-body radio-iodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin. Thyroid, 12, 37-43.
19. Hegedus, L., Hansen, B.M., Knudsen, N. & Hansen, J.M. (1988) Reduction of size of thyroid with radioactive iodine in multinodular non-toxic goiter. British Medical Journal, 297, 661-662.
20. Hooft, L., Hoekstra, O.S., Deville, W., Lips, P., Teule, G.J.J., Boers, M. & van Tulder, M.W. (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 86, 3779-3786.
21. Hosaka, Y., Tawata, M., Kurihara, A., Ohtaka, M., Endo, T. & Onaya, T. (1992) The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expression in cultured rat thyroid cells by thyrotropin. Endocrinology, 131, 159-165.
22. Huber, G.K., Fong, P., Concepcion, E.S. & Davies, T.F. (1991) Recombinant human thyroid-stimulating hormone: initial bioactivity assessment using human fetal thyroid cells. Journal of Clinical Endocrinology and Metabolism, 72, 1328-1331.
23. Huysmans, D.A., Hermus, A.R., Corstens, F.H., Barentsz, J.O. & Kloppenborg, P.W. (1994) Large, compressive goiters treated with radio-iodine. Annals of International Medicine, 121, 757-762.
24. Huysmans, D., Hermus, A., Edelbroek, M., Barentsz, J., Corstens, F. & Kloppenborg, P. (1997) Radio-iodine for nontoxic goiter. Thyroid, 7, 235-239.
25. Huysmans, D.A., Nieuwlaat, W.A., Erdtsieck, R.J., Schellekens, A.P., Bus, J.W., Bravenboer, B. & Hermus, A.R. (2000) Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radio-iodide uptake in nontoxic nodular goiter. Journal of Clinical Endocrinology and Metabolism, 85, 3592-3596.
26. Kay, T.W.H., d'Emden, M.C., Andrews, J.T. & Martin, F.I.R. (1988) Treatment of non-toxic multinodular goiter with radioactive iodine. American Journal of Medicine, 84, 19-22.
27. Ladenson, P.W., Braverman, L.E., Mazzaferri, E.L., Brucker-Davis, F., Cooper, D.S., Garber, J.R., Wondisford, F.E., Davies, TE, DeGroot, L.J., Daniels, G.H., Ross, D.S. & Weintraub, B.D. (1997) Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. New England Journal of Medicine, 337, 888-896.
28. Lawrence, J.E., Emerson, C.H., Sullaway, S.L. & Braverman, L.E. (2001) The effect of recombinant human TSH on the thyroid 123, I uptake in iodide treated normal subjects. Journal of Clinical Endocrinology and Metabolism, 86, 437-440.
29. Lippi, F., Capezzone, M., Angelini, F., Taddei, D., Molinaro, E., Pinchera, A. & Pacini, F. (2001) Radio-iodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. European Journal of Endocrinology, 144, 5-11.
30. Luster, M., Lassmann, M., Haenscheid, H., Michalowski, U., Incerti, C. & Reiners, C. (2000a) Use of recombinant human thyrotropin before radio-iodine therapy in patients with advanced differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 85, 3640-3645.
31. Luster, M., Reinhardt, W., Korber, C., Lassmann, M., Haenscheid, H., Michalowski, U., Rendl, J., Eising, E., Mann, K. & Reiners, C. (2000b) The use of recombinant human TSH in a patient with metastatic follicular carcinoma and insufficient endogenous TSH production. Journal of Endocrinologic Investigation, 23, 473-475.
32. Mariani, G., Ferdeghini, M., Augeri, C., Villa, G., Taddei, G.Z., Scopinaro, G., Boni, G., Bodei, L., Rabitti, C., Molinari, E. & Bianchi, R. (2000) Clinical experience with recombinant human thyrotropin (rhTSH) in the management of patients with differentiated thyroid cancer. Cancer Biotherapy and Radiopharmaceuticals, 15, 211-217.
33. Mazzaferri, E.L. & Jhiang, S.M. (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. American Journal of Medicine, 97, 418-428.
34. Mazzaferri, E.L. & Kloos, R.T. (2002) Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? Journal of Clinical Endocrinology and Metabolism, 87, 1490-1498.
35. Mazzaferri, E.L., Robbins, R.J., Spencer, C.A., Braverman, L.E., Pacini, F., Wartofsky, L., Haugen, B.R., Sherman, S.I., Cooper, D.S., Braunstein, G.D., Lee, S., Davies, T.F., Arafah, B.M., Ladenson, P.W. & Pincera, A. (2003) A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 1433-1441.
36. Meier, C.A., Braverman, L.E., Ebner, S.A., Veronikis, I., Daniels, G.H., Ross, D.S., Deraska, D.J., Davies, T.F., Valentine, M., DeGroot, L.J., Curran, P., McEllin, K., Reynolds, J., Robbins, J. & Weintraub, B.D. (1994) Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study). Journal of Clinical Endocrinology and Metabolism, 78, 188-196.
37. Moog, F., Linke, R., Manthey, N., Tiling, R., Knesewitsch, P., Tatsch, K. & Hahn, K. (2000) Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. Journal of Nuclear Medicine, 41, 1989-1995.
38. Nieuwlaat, W.A., Hermus, A.R., Sivro-Prndelj, F., Corstens, F.H. & Huysmans, D.A. (2001) Pretreatment with recombinant human TSH changes the regional distribution of radio-iodine on thyroid scintigrams of nodular goiters. Journal of Clinical Endocrinology and Metabolism, 86, 5330-5336.
39. Nieuwlaat, WA., Huysmans, D.A., Van den Bosch, H.C., Sweep, C.G., Ross, H.A., Corstens, F.H. & Hermus, A.R. (2003) Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radio-iodine therapy in patients with nodular goiters. Journal of Clinical Endocrinology and Metabolism, 88, 3121-3129.
40. Nygaard, B., Hegedus, L., Gervil, M., Hjalgrim, H., Soe-Jensen, P. & Hansen, J.M. (1993) Radio-iodine treatment of multinodular non-toxic goitre. British Medical Journal, 307, 828-832.
41. 131I-treatment of multinodular nontoxic goiter evaluated by flow volume loop curves. Journal of Endocrinologic Investigation, 19, 71-75.
42. Pacini, F. & Lippi, F. (1999) Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): serum thyroglobulin measurement. Journal of Endocrinological Investigation, 22 (Suppl.), 25-29.
43. Pacini, F., Molinaro, E., Lippi, F., Castagna, M.G., Agate, L., Ceccarelli, C., Taddei, D., Elisei, R., Capezzone, M. & Pinchera, A. (2001) Prediction of disease status by recombinant human TSH-stimulated serum Tg in the postsurgical follow-up of differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 5686-5690.
44. Pacini, F., Capezzone, M., Elisei, R., Ceccarelli, C., Taddei, D. & Pinchera, A. (2002a) Diagnostic 131-iodine whole body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment. Journal of Clinical Endocrinology and Metabolism, 87, 1499-1501.
45. 131I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. Journal of Clinical Endocrinology and Metabolism, 87, 4063-4068.
46. Pacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L. & Pinchera, A. (2003) Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 88, 3668-3673.
47. Pellegriti, G., Scollo, C., Giuffrida, D., Vigneri, R., Squatrito, S. & Pezzino, V. (2001) Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer. Thyroid, 11, 1025-1030.
48. Perros, P. (1999) Recombinant human thyroid-stimulating hormone (rhTSH) in the radioablation of well-differentiated thyroid cancer: preliminary therapeutic experience. Journal of Endocrinological Investigation, 22 (Suppl.), 30-34.
49. Petrich, T., Borner, A.R., Otto, D., Hofmann, M. & Knapp, W.H. (2002) Influence of rhTSH on [(18) F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. European Journal of Nuclear Medicine, 29, 641-647.
50. Ramirez, L., Braverman, L.E., White, B. & Emerson, C.H. (1997) Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects. Journal of Clinical Endocrinology and Metabolism, 82, 2836-2839.
51. Reiners, C., Luster, M. & Lassmann, M. (1999) Clinical experience with recombinant human thyroid-stimulating hormone (rhTSH): whole-body scanning with iodine-131. Journal of Endocrinological Investigation, 22 (Suppl.), 17-24.
52. 131I scanning with recombinant human thyrotropin versus thyroid hormone withdrawal in a patient with metastatic thyroid carcinoma and hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 81, 1724-1725.
53. Risse, J.H., Grunwald, F., Bender, H., Schuller, H., Van Roost, D. & Biersack, H.J. (1999) Recombinant human thyrotropin in thyroid cancer and hypopituitarism due to sella metastasis. Thyroid, 9, 1253-1256.
54. Robbins, R.J., Voelker, E., Wang, W., Macapinlac, H.A. & Larson, S.M. (2000) Compassionate use of recombinant human thyrotropin to facilitate radio-iodine therapy: case report and review of literature. Endocrine Practice, 6, 460-464.
55. Robbins, R.J., Turtle, R.M., Sharaf, R.N., Larson, S.M., Robbins, H.K., Ghossein, R.A., Smith, A. & Drucker, W.D. (2001a) Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism, 86, 619-625.
56. Robbins, R.J., Turtle, R.M., Sonenberg, M., Shaha, A., Sharaf, R., Robbins, H., Fleisher, M. & Larson, S.M. (2001b) Radio-iodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid, 11, 865-869.
57. Robbins, R.J., Chon, J.T., Fleisher, M., Larson, S.M. & Tuttle, R.M. (2002a) Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? Journal of Clinical Endocrinology and Metabolism, 87, 3242-3247.
58. Robbins, R.J., Larson, S.M., Sinha, N., Shaha, A., Divgi, C., Pentlow, K.S., Ghossein, R. & Tuttle, R.M. (2002b) A retrospective review of the effectiveness of recombinant human TSH as a preparation for radio-iodine thyroid remnant ablation. Journal of Nuclear Medicine, 43, 1482-1488.
59. 131I and recombinant human thyroid stimulating hormone. Journal of Clinical Endocrinology and Metabolism, 82, 11-14.
60. Santini, F., Bottici, V., Elisei, R., Montanelli, L., Mazzeo, S., Basolo, F., Pinchera, A. & Pacini, F. (2002) Cytotoxic effects of carboplatinum and epirubicin in the setting of an elevated serum thyrotropin for advanced poorly differentiated thyroid cancer. Journal of Clinical Endocrinology and Metabolism, 87, 4160-4165.
61. Thotakura, N.R., Desai, R.K., Bates, L.G., Cole, E.S., Pratt, B.M. & Weintraub, B.D. (1991) Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology, 128, 341-348.
62. van Tol, K.M., Jager, PL., Piers, D.A., Pruim, J., de Vries, E.G.E., Dullaart, R.P. & Links, T.P. (2002) Better yield of (18) fluorodeoxyglucose-positron emission tomography in patients with metastatic differentiated thyroid carcinoma during thyrotropin stimulation. Thyroid, 12, 381-387.
63. Torres, M.S., Ramirez, L., Simkin, P.H., Braverman, L.E. & Emerson, C.H. (2001) Effect of various doses of recombinant: human thyrotropin on the thyroid radioactive iodine uptake and serum levels of thyroid hormones and thyroglobulin in normal subjects. Journal of Clinical Endocrinology and Metabolism, 86, 1660-1664.
64. Vargas, G.E., Uy, H., Bazan, C., Guise, T.A. & Bruder, J.M. (1999) Hemiplegia after thyrotropin alfa in a hypothyroid patient with thyroid carcinoma metastatic to the brain. Journal of Clinical Endocrinology and Metabolism, 84, 3867-3871.
65. Vereist, J., Bonnyns, M. & Glinoer, D. (1990) Radio-iodine therapy in voluminous multinodular non-toxic goitre. Acta Endocrinologica (Copenhagen), 122, 417-421.
66. Wartofsky, L., and the rhTSH-Stimulated Thyroglobulin Study Group (2002) Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin. Thyroid, 12, 583-590.
67. 131I therapy in patients with non-toxic multinodular goiter. European Journal of Endocrinology, 132, 86-87.
68. Wondisford, F.E., Radovick, S., Moates, J.M., Usala, S.J. & Weintraub, B.D. (1988a) Isolation and characterization of the human thyrotropin beta-subunit gene. Differences in gene structure and promoter function from murine species. Journal of Biological Chemistry, 263, 12538-12542.
69. Wondisford, F.E., Usala, S.J., DeCherney, G.S., Castren, M., Radovick, S., Gyves, P.W., Trempe, J.P., Kerfoot, B.P., Nikodem, V.M., Carter, B.J. & Weintraub, B.D. (1988b) Cloning of the human thyrotropin beta-subunit gene and transient expression of biologically active human thyrotropin after gene transfection. Molecular Endocrinology, 2, 32-39.